GlassScriptPhysician profile
Harold J Baer
NPI 1649382920
$3,190.67
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,156 · 2020: $470 · 2021: $1,290 · 2022: $275.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $761.42 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $355.07 | 2021-2022 | |
| Horizon Therapeutics Plc | $323.27 | 2019-2022 | |
| Amgen INC. | $311.85 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $264.81 | 2019-2021 | |
| Daiichi Sankyo INC. | $237.88 | 2019-2021 | |
| Fresenius USA Marketing, INC. | $233.54 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $148.57 | 2019-2021 | |
| Vifor Pharma, INC. | $137.92 | 2019-2021 | |
| Akebia Therapeutics INC | $122.13 | 2019-2021 | |
| Angiodynamics, INC. | $90.55 | 2021 | |
| Alexion Pharmaceuticals, INC. | $39.56 | 2019-2021 | |
| Genzyme Corporation | $37.98 | 2019 | |
| Aurinia Pharma U.S., INC. | $29.18 | 2022 | |
| Mallinckrodt Hospital Products INC. | $23.53 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $19.81 | 2021 | |
| Novo Nordisk INC | $15.43 | 2021 | |
| Opko Pharmaceuticals, LLC | $13.50 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.03 | 2019 | |
| Xeris Pharmaceuticals, INC. | $11.64 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Baer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.